Menu

默沙东阿瑞匹坦效果怎么样?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

How effective is MSD?

In a randomized, double-blind, placebo-controlled, parallel-group, multicenter, phase III clinical study, the effect of aprepitant treatment regimen and standard treatment regimen for the prevention of chemotherapy-induced vomiting (CINV) was compared in 412 Chinese patients receiving chemotherapy (including cisplatin 70 mg/m2).

The aprepitant regimen included aprepitant at a dose of 125 mg on day 1 and 80 mg/day on days 2 and 3, in combination with granisetron (3 mg intravenously on day 1) and dexamethasone (6 mg on day 1 and 3.75 mg on days 2 and 4). Standard treatment consists of placebo combined with granisetron (3 mg intravenously on day 1) and dexamethasone (10.5 mg on day 1, 7.5 mg on days 2 to 4).

In Cycle 1, the antiemetic activity of aprepitant was evaluated during the acute phase (0-24 hours after cisplatin treatment), the delayed phase (25-120 hours after cisplatin treatment), and the total observation period (0-120 hours after cisplatin treatment). The primary efficacy assessment was based on the proportion of patients who reported a complete response (no vomiting and no use of rescue therapy) during the total observation period. Secondary efficacy estimates were based on the proportion of patients who reported complete remission in the acute and delayed phases, the absence of vomiting during the overall observation period, acute and delayed phases, and the absence of an impact on daily life and time to first emetic episode during the overall observation period. Exploratory evaluation was based on the proportion of patients who reported complete control and overall control in the acute phase, delayed phase, and total observation period, and no significant nausea and no nausea in the total observation period.

The therapeutic benefits of the treatment regimen were numerically superior to those of the standard treatment regimen.

Recommended related hot articles: /newsDetail/96561.html

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。